Redgumme,
Is this what you are referring to:
Announcement, date 12 May, 2003:
"Our strategy has always been to continue to build commercial value for PI-88 by providing additional clinical data to optimize value outcomes, with parallel screening of potential licensing partners for the late stage development, registration approval and marketing of PI-88".
Gerry
- Forums
- ASX - By Stock
- PGL
- drug pi-88, melanoma; how good is it?
drug pi-88, melanoma; how good is it?, page-8
Featured News
Add PGL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online